Oncogenic potential of hepatitis B virus encoded proteins

Current Opinion in Virology

Volumn 14, Issue , 2015, Pages 109-115

  Ringelhan, Marc ^a,b,c   Protzer, Ulrike ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Partner Site Munich   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; MEMBRANE PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; ONCOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CELL CYCLE PROGRESSION; CHRONIC INFLAMMATION; COPY NUMBER VARIATION; DISEASE SURVEILLANCE; DNA INTEGRATION; DNA METHYLATION; DNA REPAIR; ENDOPLASMIC RETICULUM; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; ONCOGENE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN STRUCTURE; UPREGULATION; VIRUS GENE; VIRUS REPLICATION; VIRUS X GENE; CARCINOGENESIS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY;

CARCINOGENESIS; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENE PROTEINS; VIRAL PROTEINS;

EID: 84942739809     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.08.015     Document Type: Review

References (70)

1. H.B. El-Serag Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 2012 1264-1273.e1
2. C. Trépo, H.L.Y. Chan, and A. Lok Hepatitis B virus infection Lancet 384 2014 2053 2063
3. G. Fattovich, T. Stroffolini, I. Zagni, and F. Donato Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 2004 S35 S50
4. J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, and F. Bray Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 2015 E359 E386
5. J.M. Llovet, and V. Hernandez-Gea Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design Clin Cancer Res 2014
6. A. Villanueva, V. Hernandez-Gea, and J.M. Llovet Medical therapies for hepatocellular carcinoma: a critical view of the evidence Nat Rev Gastroenterol Hepatol 10 2013 34 42
7. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
8. Y. Nakamoto, L.G. Guidotti, C.V. Kuhlen, P. Fowler, and F.V. Chisari Immune pathogenesis of hepatocellular carcinoma J Exp Med 188 1998 341 350
9. U. Protzer, M.K. Maini, and P.A. Knolle Living in the liver: hepatic infections Nat Rev Immunol 12 2012 201 213
10. C.J. Chen, and H.I. Yang Natural history of chronic hepatitis B REVEALed J Gastroenterol Hepatol 26 2011 628 638
11. C. Seeger, and W.S. Mason Molecular biology of hepatitis B virus infection Virology 479-480 2015 672 686
12. M. Nassal HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B Gut 2015
13. M. Ringelhan, T. O'Connor, U. Protzer, and M. Heikenwalder The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets J Pathol 235 2015 355 367
14. B.J. McMahon The natural history of chronic hepatitis B virus infection Hepatology 49 2009 S45 S55
15. M.A. Buendia, and C. Neuveut Hepatocellular carcinoma Cold Spring Harb Perspect Med 5 2015 a021444
16. C. Xu, W. Zhou, Y. Wang, and L. Qiao Hepatitis B virus-induced hepatocellular carcinoma Cancer Lett 345 2014 216 222
17. J. Summers, A.R. Jilbert, W. Yang, C.E. Aldrich, J. Saputelli, S. Litwin, E. Toll, and W.S. Mason Hepatocyte turnover during resolution of a transient hepadnaviral infection Proc Natl Acad Sci U S A 100 2003 11652 11659
18. W.K. Sung, H. Zheng, S. Li, R. Chen, X. Liu, Y. Li, N.P. Lee, W.H. Lee, P.N. Ariyaratne, C. Tennakoon, and et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma Nat Genet 44 2012 765 769
19. C. Seeger, and W.S. Mason Hepatitis B virus biology Microbiol Mol Biol Rev 64 2000 51 68
20. D.A. Shafritz, D. Shouval, H.I. Sherman, S.J. Hadziyannis, and M.C. Kew Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens N Engl J Med 305 1981 1067 1073
21. M.J. Bouchard, and S. Navas-Martin Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges Cancer Lett 305 2011 123 143
22. G. Amaddeo, Q. Cao, Y. Ladeiro, S. Imbeaud, J.C. Nault, D. Jaoui, Y. Gaston Mathe, C. Laurent, A. Laurent, P. Bioulac-Sage, and et al. Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas Gut 2014
23. Y. Murakami, K. Saigo, H. Takashima, M. Minami, T. Okanoue, C. Brechot, and P. Paterlini-Brechot Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas Gut 54 2005 1162 1168
24. C.C. Lau, T. Sun, A.K. Ching, M. He, J.W. Li, A.M. Wong, N.N. Co, A.W. Chan, P.S. Li, R.W. Lung, and et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression Cancer Cell 25 2014 335 349
25. A. Villanueva, and J.M. Llovet Liver cancer in 2013: mutational landscape of HCC - the end of the beginning Nat Rev Clin Oncol 11 2014 73 74
26. H.C. Hsu, T.T. Wu, J.C. Sheu, C.Y. Wu, T.J. Chiou, C.S. Lee, and D.S. Chen Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma Hepatology 9 1989 747 750
27. M. Quasdorff, M. Hosel, M. Odenthal, U. Zedler, F. Bohne, P. Gripon, H.P. Dienes, U. Drebber, D. Stippel, T. Goeser, and et al. A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation Cell Microbiol 10 2008 1478 1490
28. Q. Su, C.H. Schroder, W.J. Hofmann, G. Otto, R. Pichlmayr, and P. Bannasch Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas Hepatology 27 1998 1109 1120
29. T. Pollicino, I. Cacciola, F. Saffioti, and G. Raimondo Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications J Hepatol 61 2014 408 417
30. H.C. Wu, H.W. Tsai, C.F. Teng, W.C. Hsieh, Y.J. Lin, L.H. Wang, Q. Yuan, and I.J. Su Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis Hum Pathol 45 2014 1294 1301
31. M. Kawanaka, K. Nishino, J. Nakamura, T. Oka, N. Urata, D. Goto, M. Suehiro, H. Kawamoto, M. Kudo, and G. Yamada Quantitative levels of hepatitis B virus DNA and surface antigen and the risk of hepatocellular carcinoma in patients with hepatitis B receiving long-term nucleos(t)ide analogue therapy Liver Cancer 3 2014 41 52
32. T.C. Tseng, C.J. Liu, H.C. Yang, T.H. Su, C.C. Wang, C.L. Chen, C.A. Hsu, S.F. Kuo, C.H. Liu, P.J. Chen, and et al. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads Hepatology 57 2013 441 450
33. J. Liu, H.I. Yang, M.H. Lee, S.N. Lu, C.L. Jen, R. Batrla-Utermann, L.Y. Wang, S.L. You, C.K. Hsiao, P.J. Chen, and et al. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma Gut 63 2014 1648 1657
34. H.A. Dunsford, S. Sell, and F.V. Chisari Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice Cancer Res 50 1990 3400 3407
35. B. Na, Z. Huang, Q. Wang, Z. Qi, Y. Tian, C.C. Lu, J. Yu, M.A. Hanes, S. Kakar, E.J. Huang, and et al. Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury PLoS ONE 6 2011 e26240
36. F.V. Chisari, P. Filippi, J. Buras, A. McLachlan, H. Popper, C.A. Pinkert, R.D. Palmiter, and R.L. Brinster Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice Proc Natl Acad Sci U S A 84 1987 6909 6913
37. F.V. Chisari, K. Klopchin, T. Moriyama, C. Pasquinelli, H.A. Dunsford, S. Sell, C.A. Pinkert, R.L. Brinster, and R.D. Palmiter Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice Cell 59 1989 1145 1156
38. M. Wang, and R.J. Kaufman The impact of the endoplasmic reticulum protein-folding environment on cancer development Nat Rev Cancer 14 2014 581 597
39. V. Sosa, T. Moline, R. Somoza, R. Paciucci, H. Kondoh, and L.L. ME Oxidative stress and cancer: an overview Ageing Res Rev 12 2013 376 390
40. E. Hildt, B. Munz, G. Saher, K. Reifenberg, and P.H. Hofschneider The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice EMBO J 21 2002 525 535
41. A.S. Kekule, U. Lauer, M. Meyer, W.H. Caselmann, P.H. Hofschneider, and R. Koshy The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator Nature 343 1990 457 461
42. X. Liang, J. Du, Y. Liu, M. Cui, C. Ma, L. Han, Z. Qu, Z. Zhang, Z. Sun, L. Zhang, and et al. The hepatitis B virus protein MHBs(t) sensitizes hepatoma cells to TRAIL-induced apoptosis through ERK2 Apoptosis 12 2007 1827 1836
43. J. Lucifora, S. Arzberger, D. Durantel, L. Belloni, M. Strubin, M. Levrero, F. Zoulim, O. Hantz, and U. Protzer Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection J Hepatol 55 2011 996 1003
44. L. Belloni, T. Pollicino, F. De Nicola, F. Guerrieri, G. Raffa, M. Fanciulli, G. Raimondo, and M. Levrero Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function Proc Natl Acad Sci U S A 106 2009 19975 19979
45. T. Li, E.I. Robert, P.C. van Breugel, M. Strubin, and N. Zheng A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery Nat Struct Mol Biol 17 2010 105 111
46. P. Paterlini, K. Poussin, M. Kew, D. Franco, and C. Brechot Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma Hepatology 21 1995 313 321
47. M.A. Feitelson, A. Arzumanyan, T. Friedman, N. Lale Tufan, Z. Lian, M.M. Clayton, J. Kang, H.M.G.P.V. Reis, J. Pan, J. Liu, P. Arbuthnot, M. Kew. Mechanisms of HBx Mediated Liver Cancer: Multiple Pathways and Opportunities. In hepatocellular carcinoma - basic research. Edited by; 2012 (Ed.) DJWYL (Series Editor).
48. A. Arzumanyan, H.M. Reis, and M.A. Feitelson Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma Nat Rev Cancer 13 2013 123 135
49. X.D. Zhang, Y. Wang, and L.H. Ye Hepatitis B virus X protein accelerates the development of hepatoma Cancer Biol Med 11 2014 182 190
50. X. Qiu, S. Dong, F. Qiao, S. Lu, Y. Song, Y. Lao, Y. Li, T. Zeng, J. Hu, L. Zhang, and et al. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma Oncogene 32 2013 3296 3305
51. C.M. Kim, K. Koike, I. Saito, T. Miyamura, and G. Jay HBx gene of hepatitis B virus induces liver cancer in transgenic mice Nature 351 1991 317 320
52. D.Y. Yu, H.B. Moon, J.K. Son, S. Jeong, S.L. Yu, H. Yoon, Y.M. Han, C.S. Lee, J.S. Park, C.H. Lee, and et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein J Hepatol 31 1999 123 132
53. O. Terradillos, O. Billet, C.A. Renard, R. Levy, T. Molina, P. Briand, and M.A. Buendia The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice Oncogene 14 1997 395 404
54. B.L. Slagle, T.H. Lee, D. Medina, M.J. Finegold, and J.S. Butel Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene Mol Carcinog 15 1996 261 269
55. J.K. Jung, P. Arora, J.S. Pagano, and K.L. Jang Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway Cancer Res 67 2007 5771 5778
56. L. Riviere, L. Gerossier, A. Ducroux, S. Dion, Q. Deng, M.L. Michel, M.A. Buendia, O. Hantz, and C. Neuveut HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase J Hepatol 2015
57. S.H. Park, J.K. Jung, J.S. Lim, I. Tiwari, and K.L. Jang Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation J Gen Virol 92 2011 1309 1317
58. R. Zhu, M.T. Mok, W. Kang, S.S. Lau, W.K. Yip, Y. Chen, P.B. Lai, V.W. Wong, K.F. To, J.J. Sung, and et al. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis J Pathol 2015
59. X.W. Wang, K. Forrester, H. Yeh, M.A. Feitelson, J.R. Gu, and C.C. Harris Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3 Proc Natl Acad Sci U S A 91 1994 2230 2234
60. C. Chan, Y. Wang, P.K. Chow, A.Y. Chung, L.L. Ooi, and C.G. Lee Altered binding site selection of P53 transcription cassettes by hepatitis B virus X protein Mol Cell Biol 2012
61. K. Yuan, Z.R. Lian, B. Sun, M.M. Clayton, I.O.L. Ng, and M.A. Feitelson Role of miR-148a in hepatitis B associated hepatocellular carcinoma PLOS ONE 2012 7
62. B. Yang, and M.J. Bouchard The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake J Virol 86 2012 313 327
63. M.J. Bouchard, and R.J. Schneider The enigmatic X gene of hepatitis B virus J Virol 78 2004 12725 12734
64. P. Paterlini, K. Poussin, M. Kew, D. Franco, and C. Brechot Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma Hepatology 21 1995 313 321
65. S. Lee, C. Tarn, W.H. Wang, S. Chen, R.L. Hullinger, and O.M. Andrisani Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines J Biol Chem 277 2002 8730 8740
66. J.O. Lee, H.J. Kwun, J.K. Jung, K.H. Choi, D.S. Min, and K.L. Jang Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1 Oncogene 24 2005 6617 6625
67. A. Arzumanyan, T. Friedman, E. Kotei, I.O.L. Ng, Z. Lian, and M.A. Feitelson Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer Oncogene 31 2012 563 572
68. S.L. Ding, Z.W. Yang, J. Wang, X.L. Zhang, X.M. Chen, and F.M. Lu Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma World J Gastroenterol 21 2015 6317 6328
69. Q. Wang, T. Zhang, L. Ye, W. Wang, and X. Zhang Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China Cancer Epidemiol 36 2012 369 374
70. Y. Xie, S. Liu, Y. Zhao, Z. Guo, and J. Xu X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma Tumour Biol 2014